Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Prospective real-world evidence of mental health outcomes following supervised psilocybin services within the Oregon state-regulated modelmedRxiv · 2026-08-17Defining 'psychedelic'.Journal of psychopharmacology (Oxford, England) · 2026-08-17The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisJournal of Affective Disorders · 2026-08-01Psilocybin therapy for adult females with anorexia nervosa: pilot studyThe British Journal of Psychiatry · 2026-07-08Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic CircuitsHuman Brain Mapping · 2026-07-01Divergent changes in perturbation-induced brain reconfiguration following depression treatment with psilocybin and escitaloprambioRxiv · 2026-06-26Sex-Specific Effects of Psilocybin Versus Escitalopram on Anxiety and Anhedonia: A Bayesian Reanalysis of Antidepressant Treatment OutcomesResearch Square · 2026-06-19Distinct brain responses to psilocybin and escitalopram in depression captured by the Fluctuation-Dissipation TheorembioRxiv · 2026-06-16Multivariate Neural and Physiological Correlates of Psychedelic Sub-states: a Within-subjects, Healthy Volunteer Study With Experience-samplingClinicalTrials.gov · 2026-06-05Correction to: Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic ActionCurrent Psychiatry Reports · 2026-06-052 x 2 Factorial, Double-blind, Randomized Trial of 'Set and Setting': a Translational Study in Healthy VolunteersClinicalTrials.gov · 2026-06-04Neural correlates of insight on psilocybin: a within-subjects, healthy volunteer studyJoCN Forum · 2026-05-08Human brain changes after first psilocybin useNature Communications · 2026-05-05Effects of psychedelic use on authoritarian attitudes revisited.Journal of psychopharmacology (Oxford, England) · 2026-05-01Observing the mind under psychedelics: conceptual metaphors used following four once-weekly macrodoses of psilocybinPhilosophical Psychology · 2026-04-10An international mega-analysis of psychedelic drug effects on brain circuit function.Nature medicine · 2026-04-01Classic psychedelics in obsessive-compulsive disorder: a circuit-based frameworkNature Mental Health · 2026-03-31The combination of exercise and psychedelics for the treatment of major depressive disorder.Discover mental health · 2026-03-07Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].Journal of affective disorders · 2026-01-15The entropic brain todayPsyArXiv · 2025-12-12The entropic brain todayPsyArXiv · 2025-12-12Short- and long-term modulation of rat prefrontal cortical activity following single doses of psilocybin.Molecular psychiatry · 2025-12-01Correction: Short- and long-term modulation of rat prefrontal cortical activity following single doses of psilocybin.Molecular psychiatry · 2025-12-01Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis.European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology · 2025-12-01Negative affective bias in depression following treatment with psilocybin or escitalopram - a secondary analysis from a randomized trial.Translational psychiatry · 2025-11-13Correction: Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenologyTranslational Psychiatry · 2025-11-12N,N-dimethyltryptamine effects on connectome harmonics, subjective experience and comparative psychedelic experiences.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2025-11-01Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study.Comprehensive psychiatry · 2025-10-01Blunted psychedelic drug effects in older adultsPsyArXiv · 2025-09-04Blunted psychedelic drug effects in older adultsPsyArXiv · 2025-09-04A lexicon for psychedelic research and treatmentDrug Science Policy and Law · 2025-08-31Psychedelic Therapy, Positive Emotional Experiences, and the Central Role of Self-Compassion.Research square · 2025-08-22Accurate and Interpretable Prediction of Antidepressant Treatment Response from Receptor-informed NeuroimagingbioRxiv · 2025-07-03Exploring serotonergic psychedelics as a treatment for personality disorders.Neuropharmacology · 2025-07-01Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises.Molecular psychiatry · 2025-07-01Correction: Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises.Molecular psychiatry · 2025-07-01Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat Settings.Brain and behavior · 2025-07-01Psilocybin for disorders of consciousness: A case-report study.Clinical neurophysiology: official journal of the International Federation of Clinical Neurophysiology · 2025-05-01Neuroplasticity and psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical models.Neuroscience and biobehavioral reviews · 2025-05-01The effects of psilocybin therapy versus escitalopram on cognitive bias: A secondary analysis of a randomized controlled trialmedRxiv · 2025-03-21Psychedelics Align Brain Activity with ContextbioRxiv · 2025-03-11Revealing Changes in Linear and Nonlinear Functional Connectivity After Psilocybin and Escitalopram Treatment in Patients with DepressionbioRxiv · 2025-03-10The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.Journal of affective disorders · 2025-03-01A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.Psychedelic medicine (New Rochelle, N.Y.) · 2025-03-01A qualitative analysis of the psychedelic mushroom come-up and come-down.Npj mental health research · 2025-02-07Examining differences in the effects and contexts of naturalistic psilocybin use for White participants vs. Participants of Color: A longitudinal online survey study.Journal of affective disorders · 2025-02-01From relaxed beliefs under psychedelics (REBUS) to revised beliefs after psychedelics (REBAS).Scientific reports · 2025-01-29Perturbing whole-brain models of brain hierarchy: an application for depression following pharmacological treatmentbioRxiv · 2025-01-02Effects of escitalopram and psilocybin therapy on mesolimbic resting-state functional connectivity in depressionNeuroscience Applied · 2025-01-01Human neuroimaging: fMRI.International review of neurobiology · 2025-01-01An investigation of acute physiological and psychological moderators of psychedelic-induced personality change among healthy volunteers.Neuroscience applied · 2025-01-01Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.Cureus · 2025-01-01Correction: Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.Cureus · 2025-01-01Enhanced meaning in life following psychedelic use: converging evidence from controlled and naturalistic studies.Frontiers in psychology · 2025-01-01Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in a psilocybin retreat.Frontiers in psychiatry · 2025-01-01Brain dynamics of classical psychedelics show paradoxical hierarchical flattening with increased complexitybioRxiv · 2024-12-22Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenology.Translational psychiatry · 2024-12-04Long-term effects of psilocybin on dynamic and effectivity connectivity of fronto-striatal-thalamic circuitsbioRxiv · 2024-11-07Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic Action.Current psychiatry reports · 2024-11-01Human brain changes after first psilocybin usebioRxiv · 2024-10-14Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial.EClinicalMedicine · 2024-10-01A virtual clinical trial of psychedelics to treat patients with disorders of consciousnessbioRxiv · 2024-08-19Different hierarchical reconfigurations in the brain by psilocybin and escitalopram for depressionNature Mental Health · 2024-08-05Psilocybin desynchronizes the human brain.Nature · 2024-08-01Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy.Scientific reports · 2024-07-17Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression.Psychological medicine · 2024-06-01Time-resolved coupling between connectome harmonics and subjective experience under the psychedelic DMT.bioRxiv: the preprint server for biology · 2024-05-30Predicting the outcome of psilocybin treatment for depression from baseline fMRI functional connectivity.Journal of affective disorders · 2024-05-15Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression.Journal of psychopharmacology (Oxford, England) · 2024-05-01Psychedelics and the 'inner healer': Myth or mechanism?Journal of psychopharmacology (Oxford, England) · 2024-05-01Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive DisorderInternational Journal of Mental Health and Addiction · 2024-03-07The Temporal Trajectory of the Psychedelic Mushroom Experience Mimics the Narrative Arc of the Hero’s JourneyResearch Square · 2024-02-23Effects of DMT on mental health outcomes in healthy volunteers.Scientific reports · 2024-02-07Psychedelics and sexual functioning: a mixed-methods study.Scientific reports · 2024-02-07Psilocybin vs Escitalopram for depression: 6-month follow-upNeuroscience Applied · 2024-01-01Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression.Psychological medicine · 2024-01-01Personality Change in a Trial of Psilocybin Therapy vs Escitalopram Treatment for Depression - CORRIGENDUM.Psychological medicine · 2024-01-01Psilocybin and Other Classic Psychedelics in Depression.Current topics in behavioral neurosciences · 2024-01-01Study protocol for "Psilocybin in patients with fibromyalgia: brain biomarkers of action".Frontiers in psychiatry · 2024-01-01Within-subject comparison of near-death and psychedelic experiences: acute and enduring effects.Neuroscience of consciousness · 2024-01-01Statistical diversity distinguishes global states of consciousnessbioRxiv · 2023-12-07The entropic heart: Tracking the psychedelic state via heart rate dynamicsbioRxiv · 2023-11-09Synergistic, Multi-level Understanding of Psychedelics: Three Systematic Reviews and Meta-analyses of Their Pharmacology, Neuroimaging and PhenomenologybioRxiv · 2023-10-07Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis.Psychiatry research · 2023-09-01Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences.Scientific reports · 2023-08-22How does psilocybin therapy work? An exploration of experiential avoidance as a putative mechanism of change.Journal of affective disorders · 2023-08-01A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression.Journal of psychopharmacology (Oxford, England) · 2023-07-01In vivo mapping of pharmacologically induced functional reorganization onto the human brain's neurotransmitter landscape.Science advances · 2023-06-16Reduced brain responsiveness to emotional stimuli with escitalopram but not psilocybin therapy for depressionmedRxiv · 2023-06-03Time-resolved network control analysis links reduced control energy under DMT with the serotonin 2a receptor, signal diversity, and subjective experience.bioRxiv: the preprint server for biology · 2023-05-12Canalization and plasticity in psychopathology.Neuropharmacology · 2023-03-15A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression.Psychedelic medicine (New Rochelle, N.Y.) · 2023-03-01Psilocybin as a treatment for anorexia nervosa: 6-week and 3-month follow-up resultsNeuroscience Applied · 2023-01-01Body mass index (BMI) does not predict responses to psilocybin.Journal of psychopharmacology (Oxford, England) · 2023-01-01Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression.Journal of psychopharmacology (Oxford, England) · 2023-01-01Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness.Journal of psychopharmacology (Oxford, England) · 2023-01-01Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.The New England journal of medicine · 2022-11-03The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world.Psychopharmacology · 2022-11-01Evidence for tolerance in psychedelic microdosing from the self-blinding microdose trialPsyArXiv · 2022-10-19Receptor-informed network control theory links LSD and psilocybin to a flattening of the brain's control energy landscape.Nature communications · 2022-10-03Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language ProcessingPsyArXiv · 2022-09-30Brain dynamics predictive of response to psilocybin for treatment-resistant depressionResearch Square · 2022-09-20Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-17Effects of psilocybin versus escitalopram on rumination and thought suppression in depression.BJPsych open · 2022-09-06Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex.NeuroImage · 2022-08-01Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample.Journal of psychopharmacology (Oxford, England) · 2022-08-01Mapping Pharmacologically-induced Functional Reorganisation onto the Brain’s Neurotransmitter LandscapebioRxiv · 2022-07-13From Relaxed Beliefs Under Psychedelics (REBUS) to Revised Beliefs After Psychedelics (REBAS): Preliminary Development of the RElaxed Beliefs Questionnaire (REB-Q)PsyArXiv · 2022-07-07From Relaxed Beliefs Under Psychedelics (REBUS) to Revised Beliefs After Psychedelics (REBAS): Preliminary Development of the RElaxed Beliefs Questionnaire (REB-Q)PsyArXiv · 2022-07-07Brain dynamics predictive of response to psilocybin for treatment-resistant depressionbioRxiv · 2022-07-04Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses.Neuroscience and biobehavioral reviews · 2022-07-01A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for DepressionPsyArXiv · 2022-07-01A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for DepressionPsyArXiv · 2022-07-01A critique of: Skepticism About Recent Evidence that Psilocybin Opens Depressed MindsPsyArXiv · 2022-05-10A critique of: Skepticism About Recent Evidence that Psilocybin Opens Depressed MindsPsyArXiv · 2022-05-10Increased global integration in the brain after psilocybin therapy for depression.Nature medicine · 2022-04-01Increased low-frequency brain responses to music after psilocybin therapy for depressionbioRxiv · 2022-02-15Psychedelics and health behaviour change.Journal of psychopharmacology (Oxford, England) · 2022-01-01Effects of classic psychedelic drugs on turbulent signatures in brain dynamics.Network neuroscience (Cambridge, Mass.) · 2022-01-01P.0353 Study protocol: psilocybin as a treatment for anorexia nervosa: a pilot studyEuropean Neuropsychopharmacology · 2021-12-01P.0885 The effect of psilocybin therapy for depression on low-frequency brain activity in response to musicEuropean Neuropsychopharmacology · 2021-12-01Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online surveyPsychopharmacology · 2021-11-03Psilocybin for Depression.The New England journal of medicine · 2021-08-26Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analysesPsyArXiv · 2021-06-10Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analysesPsyArXiv · 2021-06-10Decreased brain modularity after psilocybin therapy for depression.Research Square · 2021-05-20LSD and psilocybin flatten the brain’s energy landscape: insights from receptor-informed network control theorybioRxiv · 2021-05-17Association Between Lifetime Classic Psychedelic Use and Hypertension in the Past Year.Hypertension (Dallas, Tex.: 1979) · 2021-05-05Trial of Psilocybin versus Escitalopram for Depression.The New England journal of medicine · 2021-04-15Psychedelics and Health Behavior Change - Journal of Psychopharmacology (in press)PsyArXiv · 2021-03-24Psychedelics and Health Behavior Change - Journal of Psychopharmacology (in press)PsyArXiv · 2021-03-24Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies.Acta psychiatrica Scandinavica · 2021-02-01Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample.Frontiers in psychiatry · 2021-01-01Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential?Frontiers in psychiatry · 2021-01-01Trends in the Top-Cited Articles on Classic Psychedelics.Journal of psychoactive drugs · 2021-01-01Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study".Frontiers in psychiatry · 2021-01-01Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.Frontiers in pharmacology · 2021-01-014 Psychedelics: therapeutic mechanismsJournal of Neurology Neurosurgery & Psychiatry · 2020-07-20Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortexbioRxiv · 2020-05-03Dynamic coupling of whole-brain neuronal and neurotransmitter systems.Proceedings of the National Academy of Sciences of the United States of America · 2020-04-28Psychedelic Psychiatry's Brave New World.Cell · 2020-04-02Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression.Journal of psychopharmacology (Oxford, England) · 2020-02-01P.609 Therapeutic mechanisms of psychedelic drugs: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depressionEuropean Neuropsychopharmacology · 2019-12-01Replication and extension of a model predicting response to psilocybin.Psychopharmacology · 2019-11-01Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives.NeuroImage · 2019-10-15Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin.NeuroImage · 2019-10-01Decreased Directed Functional Connectivity in the Psychedelic StatebioRxiv · 2019-07-16REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics.Pharmacological reviews · 2019-07-01Serotonergic Psychedelics LSD & Psilocybin Increase the Fractal Dimension of Cortical Brain Activity in Spatial and Temporal DomainsbioRxiv · 2019-01-11Psychedelics as a treatment for disorders of consciousness.Neuroscience of consciousness · 2019-01-01Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression.Neuropharmacology · 2018-11-01Effects of psilocybin therapy on personality structure.Acta psychiatrica Scandinavica · 2018-11-01Serotonin, psychedelics and psychiatryWorld Psychiatry · 2018-09-07Altered trajectories in the dynamical repertoire of functional network states under psilocybinbioRxiv · 2018-07-25Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression.Journal of psychopharmacology (Oxford, England) · 2018-07-01Psilocybin and MDMA reduce costly punishment in the Ultimatum Game.Scientific reports · 2018-05-29Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression.Journal of affective disorders · 2018-04-01Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression.Psychopharmacology · 2018-02-01Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.Psychopharmacology · 2018-02-01The hidden therapist: evidence for a central role of music in psychedelic therapy.Psychopharmacology · 2018-02-01Common neural signatures of psychedelics: Frequency-specific energy changes and repertoire expansion revealed using connectome-harmonic decomposition.Progress in brain research · 2018-01-01Psychedelics, Meditation, and Self-Consciousness.Frontiers in psychology · 2018-01-01More Realistic Forecasting of Future Life Events After Psilocybin for Treatment-Resistant Depression.Frontiers in psychology · 2018-01-01Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.Scientific reports · 2017-10-13The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2017-10-01Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant DepressionJournal of Humanistic Psychology · 2017-06-19Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin.Scientific reports · 2017-04-19Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression.Frontiers in pharmacology · 2017-01-01Question-based Drug Development for psilocybin - Authors' reply.The lancet. Psychiatry · 2016-09-01Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.The lancet. Psychiatry · 2016-07-01Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin.Human brain mapping · 2015-08-01Drug models of schizophrenia.Therapeutic advances in psychopharmacology · 2015-02-01Homological scaffolds of brain functional networks.Journal of the Royal Society, Interface · 2014-12-06Enhanced repertoire of brain dynamical states during the psychedelic experience.Human brain mapping · 2014-11-01A qualitative report on the subjective experience of intravenous psilocybin administered in an FMRI environment.Current drug abuse reviews · 2014-01-01The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs.Frontiers in human neuroscience · 2014-01-01The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers.Frontiers in human neuroscience · 2014-01-01Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis.Schizophrenia bulletin · 2013-11-01Broadband cortical desynchronization underlies the human psychedelic state.The Journal of neuroscience: the official journal of the Society for Neuroscience · 2013-09-18Psychiatry's next top model: cause for a re-think on drug models of psychosis and other psychiatric disorders.Journal of psychopharmacology (Oxford, England) · 2013-09-01PSYCHEDELIC DRUGS, MAGICAL THINKING AND PSYCHOSISJournal of Neurology Neurosurgery & Psychiatry · 2013-08-06Experienced drug users assess the relative harms and benefits of drugs: a web-based survey.Journal of psychoactive drugs · 2013-01-01Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin.The British journal of psychiatry: the journal of mental science · 2012-03-01Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.Proceedings of the National Academy of Sciences of the United States of America · 2012-02-07The administration of psilocybin to healthy, hallucinogen-experienced volunteers in a mock-functional magnetic resonance imaging environment: a preliminary investigation of tolerability.Journal of psychopharmacology (Oxford, England) · 2011-11-01P.1.e.017 The functional brain correlates of the psychedelic state: an arterial spin labelling study with psilocybinEuropean Neuropsychopharmacology · 2011-08-07